Medical AI startup Boltz raises $110M to speed up small molecule research
SiliconAngle reports that Boltz PBC, a startup that develops artificial intelligence models for pharmaceutical researchers, has raised $110 million in Series A funding led by Bessemer. According to the outlet, Boltz said on Wednesday that the round included new and returning backers such as Greycroft, Andreessen Horowitz, Amplify Partners, F-Prime Capital and Hummingbird. The headline says the funding is aimed at speeding up small molecule research.
Based on SiliconAngle's report - only one outlet has covered this so far. Read the original.Coverage 1 source · 1 report
Chronological.
-
Medical AI startup Boltz raises $110M to speed up small molecule research
Boltz PBC, a startup that develops artificial intelligence models for pharmaceutical researchers, has raised $110 million in funding. Bessemer led the Series A investment. Boltz stated on Wednesday that the fund was joined by a large group of new and returning backers. The consortium included Greycroft, Andreessen Horowitz, Amplify Partners, F-Prime Capital, Hummingbird and others. […] The post Medical AI startup Boltz raises $110M to speed up small molecule research appeared first on SiliconANG
Discussion 0 comments